Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brian Kim MD, MTR, FAAD

Brian S. Kim MD, MTR, FAAD

Sol and Clara Kest Professor of Dermatology and Vice Chair of Research, Kimberly and Eric J. Waldman Department of Dermatology, Precision Immunology Institute, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York

Dr. Kim received his MD from the University of Washington, was a HHMI-NIH Scholar, completed residency in dermatology at the University of Pennsylvania where he earned a Master of Translational Research (MTR). The Kim Lab focuses on mechanisms that underlie skin inflammation and the sensation of itch as a fundamental, broad, model paradigm of neuroimmunology. Key discoveries include the first identification of group 2 innate lymphoid cells (ILC2s) in the skin of both mice and humans, novel contributions of basophils, ILC2s, and natural killer (NK) cells to skin inflammation, and unveiling how immune cells and type 2 cytokines/JAK signaling directly influence sensory neuronal responses. He has >160 peer-reviewed publications, multiple NIH grants, designed pivotal clinical trials that led to novel FDA-approved treatments, and is an inventor of itch-centered technologies. His research has led to awards and funding from NIH, Doris Duke Charitable Foundation, American Skin Association, American Academy of Dermatology, American Society for Clinical Investigation, American Dermatological Association, and International League of Dermatological Societies. He holds a patent for the use of JAK inhibitors for chronic itch. He is on the scientific advisory board for Abrax Japan, Granular Therapeutics, Recens Medical, National Eczema Association, and Cell Reports Medicine. He is on the editorial board of Journal of Allergy and Clinical Immunology, section editor for Journal of Immunology and on the board of reviewing editors for eLife.

Summary of Research: Understanding how the sensory nervous system interacts with the immune system to shape behavior and tissue inflammation.

Dr. Kim's current title(s): Sol and Clara Kest Professor of Dermatology, Vice Chair of Research, Site Chair Mount Sinai West and Morningside, Director of the Mark Lebwohl Center for Neuroinflammation and Sensation, Director of the Allen Discovery Center for Neuroimmune Interactions, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation.

Dr. Kim's current affiliation(s): Kimberly and Eric J. Waldman Department of Dermatology, Precision Immunology Institute, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai.

Social Media: @itchdoctor;


No disclosures noted.